Inventor · disambiguated record
Gurdip Bhalay
Also filed as: BHALAY GURDIP
22 granted patents·9 pending applications·37 citations·filing 1998–2019
92Inventor score
Top patents by PatentIndex Score
31 records- 0187US8039472B2Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channelNOVARTIS AG·Filed 2008·Granted Oct 18, 2011·8 cites·19 claims
- 0283US9050339B2Pyrazine derivatives as ENaC blockersNOVARTIS AG·Filed 2012·Granted Jun 9, 2015·2 cites·8 claims
- 0377US8546416B23-spirocyclic piperidine derivatives as ghrelin receptor agonistsAMBARKHANE AMEET VIJAY·Filed 2012·Granted Oct 1, 2013·8 cites·11 claims
- 0476US9139586B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2014·Granted Sep 22, 2015·2 cites·7 claims
- 0574US8697687B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2012·Granted Apr 15, 2014·2 cites·3 claims
- 0673US6919337B28-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsNOVARTIS AG·Filed 2003·Granted Jul 19, 2005·9 cites·15 claims
- 0772US8372845B2Pyrazine derivatives as enac blockersNOVARTIS AG·Filed 2011·Granted Feb 12, 2013·2 cites·16 claims
- 0870US8168654B2Quinuclidine derivatives binding to mucarinic M3 receptorsCOLLINGWOOD STEPHEN P·Filed 2009·Granted May 1, 2012·2 cites·16 claims
- 0964US10954236B2Tyrosine amide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2019·Granted Mar 23, 2021·0 cites·15 claims
- 1062US2006173181A18-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2005·Application pending·0 cites
- 1161US6670379B2Piperidine compounds for use as ccr-3 inhibitorsNOVARTIS AG·Filed 2001·Granted Dec 30, 2003·2 cites·20 claims
- 1259US7361661B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsBHALAY GURDIP·Filed 2006·Granted Apr 22, 2008·0 cites·3 claims
- 1355US7019136B28-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitorsNOVARTIS AG·Filed 2004·Granted Mar 28, 2006·0 cites·1 claims
- 1454US10501461B2Tyrosine amide derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Dec 10, 2019·0 cites·14 claims
- 1554US9522149B2Pyrazine derivatives as ENaC blockersNOVARTIS AG·Filed 2015·Granted Dec 20, 2016·0 cites·2 claims
- 1653US9643983B2Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivativesBHALAY GURDIP·Filed 2015·Granted May 9, 2017·0 cites·6 claims
- 1751US2021284639A1Tyrosine amide derivatives as rho- kinase inhibitorsCHIESI FARM SPA·Filed 2019·Application pending·0 cites
- 1851US2017143705A1Pyrazine derivatives as enac blockersNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1948US11725007B2Meta tyrosine derivatives as rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Aug 15, 2023·0 cites·13 claims
- 2046US11147812B2Tyrosine analogues derivatives as Rho-kinase inhibitorsCHIESI FARM SPA·Filed 2018·Granted Oct 19, 2021·0 cites·14 claims
- 2145US10584128B2Bicyclic dihydropyrimidine-carboxamide derivatives as Rho-Kinase inhibitorsCHIESI FARM SPA·Filed 2017·Granted Mar 10, 2020·0 cites·14 claims
- 2245US2007060563A1Quinuclidine derivatives binding to mucarinic m3 receptorsCOLLINGWOOD STEPHEN P·Filed 2004·Application pending·0 cites
- 2343US2009082365A1Trisubstituted Quinazolinone Derivatives as Vanilloid AntagonistsNOVARTIS AG·Filed 2006·Application pending·0 cites
- 2442US2013331369A13-Spirocyclic Piperidine Derivatives as Ghrelin Receptor AgonistsAMBARKHANE AMEET VIJAY·Filed 2013·Application pending·0 cites
- 2541US2014357641A1IP receptor agonist heterocyclic compoundsNOVARTIS AG·Filed 2013·Application pending·0 cites
- 2640US7259173B2Derivatives of 3-phenyl-n-(2-(4-benzyl)-piperidin-1-yl)-ethyl)-acrylamid with ccr-3-receptor antagonistic activity for use in the treatment of inflammations and allergic conditionsNOVARTIS AG·Filed 2002·Granted Aug 21, 2007·0 cites·14 claims
- 2739US7754758B2Pyrrolidine derivatives acting as CCR3-receptor antagonistsNOVARTIS AG·Filed 2005·Granted Jul 13, 2010·0 cites·8 claims
- 2839US2003171384A18-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitorsFiled 2001·Application pending·0 cites
- 2937US7034042B2N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as CCR33 receptor antagonistsNOVARTIS AG·Filed 2001·Granted Apr 25, 2006·0 cites·16 claims
- 3037US2008096943A1Organic CompundsBHALAY GURDIP·Filed 2005·Application pending·0 cites
- 3129US6114468ASynthetic resins for use in solid phase synthesisNOVARTIS AG·Filed 1998·Granted Sep 5, 2000·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →